Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

StressGen launches new research initiative in allergy and asthma

Sep. 20, 1999

Boston Life Sciences and Pfizer sign allergy licensing agreement

Sep. 15, 1999

The Cystic Fibrosis Foundation funds drug discovery program at Aurora

Sep. 14, 1999

Alinastine: pharmacological properties indicate benefit in seasonal allergic rhinoconjunctivitis

Sep. 14, 1999

VUF-K-8788: new antiallergic agent characterized in experimental studies

Sep. 13, 1999

Protease-inhibitory cephams and cephems and their use patented by Pliva

Sep. 13, 1999

Phthalazinones synthesized at Byk Gulden specifically inhibit PDE4

Sep. 10, 1999

Agents for allergic diseases in development by Dainippon Ink & Chemicals

Sep. 10, 1999

German collaboration yields new inhibitors of human tryptase

Sep. 7, 1999

Glaxo Wellcome patents improved adenosine A2A receptor agonists as antiinflammatory agents

Sep. 6, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...